Enalapril-induced apoptosis of acute promyelocytic leukaemia cells involves STAT5A

Anticancer Research

Volumn 32, Issue 7, 2012, Pages 2885-2894

  Purclutepe, Ozlem ^a   Iskender, Guniz ^b   Kiper, Hatice Demet ^a   Tezcanli, Burcin ^a   Selvi, Nur ^a   Avci, Cigir Biray ^a   Kosova, Buket ^a   Gokbulut, Aysun Adan ^b   Sahin, Fahri ^a   Baran, Yusuf ^b   Saydam, Guray ^a  

^a EGE UNIVERSITY   (Turkey)

^b IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Acute promyelocytic leukaemia; Apoptosis; Cytotoxicity; Enalapril; Hl60 cells; STATs

Indexed keywords

ENALAPRIL; STAT3 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; GENE EXPRESSION; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 84865701433     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33: 451-458, 1976.
2. Chen Z, Tong JH, Dong S, Zhu J, Wang ZY and Chen SJ: Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia. Genes Chromosom Cancer 15: 147-156, 1996. (Pubitemid 26112506)
3. Sanz MA, Jarque I, Martin G, Lorenzo I, Martínez J, Rafecas J, Pastor E, Sayas MJ, Sanz G and Gomis F: Acute promyelocytic leukemia. Therapy results and prognostic factors. Cancer 61: 7-13, 1988.
4. Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN and Clarkson BD: Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 73: 1116-1122, 1989. (Pubitemid 19107411)
5. Fenaux P, Wang ZZ and Degos L: Treatment of acute promyelocytic leukemia by retinoids. Curr Top Microbiol Immunol 313: 101-128, 2007. (Pubitemid 47400335)
6. Huang ME, Ye YC, Chen SR, Zhao JC, Gu LJ, Cai JR, Zhao L, Xie JX, Shen ZX and Wang ZY: All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia. Report of 6 cases. Chin Med J 100: 949-953, 1987. (Pubitemid 18080731)
7. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ and Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572, 1988.
8. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G,Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A and Lo Coco F: Molecular remission in PML. RAR-alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 90: 1014-1021, 1997.
9. Sanz MA, Martin G, Rayon C, Esteve J, Gonzalez M, Diaz-Mediavilla J, Bolufer P, Barragan E, Terol MJ, Gonzalez JD, Colomer D, Chillon C, Rivas C, Gomez T, Ribera JM, Bornstein R, Roman J, Calasanz MJ, Arias J, Alvarez C, Ramos F and Deben G: A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia. PETHEMA group. Blood 94: 3015-3021, 1999. (Pubitemid 29512705)
10. Asou N, Kishimoto Y, Kiyoi H, Okada M, Kawai Y, Tsuzuki M, Horikawa K, Matsuda M, Shinagawa K, Kobayashi T, Ohtake S, Nishimura M, Takahashi M,Yagasaki F, Takeshita A, Kimura Y, Iwanaga M, Naoe T and Ohno R; Japan Adult Leukemia Study Group: A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study. Blood 110: 59-66, 2007. (Pubitemid 47026819)
11. Douer D and Tallman MS: Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 23: 2396-2410, 2005. (Pubitemid 46218734)
12. Darnell JE Jr.: STATs and gene regulation. Science 277: 1630-1635, 1997.
13. Darnell JE Jr., Kerr IM and Stark GR: JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421, 1994. (Pubitemid 24217131)
14. Garcia R and Jove R: Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci 5: 79-85, 1998. (Pubitemid 28253097)
15. Bowman T, Garcia R, Turkson J and Jove R: STATs in oncogenesis. Oncogene 19: 2474-2488, 2000. (Pubitemid 30339203)
16. Bromberg JF, Horvath CM, Wen Z, Schreiber RD and Darnell JE Jr.: Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci USA 93: 7673-7678, 1996 (Pubitemid 26277095)
17. Levy DE and Gilliland DG: Divergent roles of Stat1 and Stat5 in malignancy as revealed by gene disruptions in mice. Oncogene 19: 2505-2510, 2000. (Pubitemid 30339206)
18. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-Luna JL, Nunez G, Dalton WS and Jove R: Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115, 1999. (Pubitemid 29077388)
19. Puthier D, Thabard W, Rapp M, Etrillard M, Harousseau J, Bataille R and Amiot M: Interferon alpha extends the survival of human myeloma cells through an up regulation of the Mcl-1 antiapoptotic molecule. Br J Haematol 112: 358-363, 2001. (Pubitemid 32183477)
20. Deshayes F and Nahmias C: Angiotensin receptors: A new role in cancer? Trends Endocrinol Metab 16: 293-299, 2005. (Pubitemid 41206635)
21. Dzau V: Tissue renin-angiotensin system: physiologic and pharmacologic implications. Circulation 77: 1-2, 1988.
22. Haznedaroglu IC and Ozturk MA: Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 35: 867-880, 2003. (Pubitemid 36379328)
23. Strawn WB, Richmond RS, Tallant EA, Gallagher PE, Ferrario CM: Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 126: 120-126, 2004. (Pubitemid 38859492)
24. Hubert C, Savary K, Gasc JM and Corvol P: The hematopoietic system: a new niche for the renin-angiotensin system. Nat Clin Pract Cardiovasc Med 3: 80-85, 2006. (Pubitemid 43203376)
25. Ager EI, Neo J and Christophi C: The renin-angiotensin system and malignancy. Carcinogenesis 29: 1675-1684, 2008.
26. Beyazit Y, Aksu S, Haznedaroglu IC, Kekilli M, Misirlioglu M, Tuncer S, Karakaya J, Koca E, Buyukasik Y, Sayinalp N and Goker H: Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. J Natl Med Assoc 99: 57-63, 2007. (Pubitemid 46183959)
27. Koca E, Haznedaroglu IC, Acar K, Beyazit Y, Aksu S, Misirlioglu M, Tuncer S, Sayinalp N, Ozcebe OI and Uner A: Renin-angiotensin system expression in the K562 human erythroleukemic cell line. J Renin Angiotensin Aldosterone Syst 8: 145-147, 2007. (Pubitemid 350148452)
28. Koca E, Haznedaroglu IC, Uner A, Sayinalp N, Saglam AE, Goker H and Ozcebe OI: Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease. J Natl Med Assoc 99: 1243-1247, 2007. (Pubitemid 350246906)
29. Aksu S, Beyazit Y, Haznedaroglu IC, Canpinar H, Kekilli M, Uner A, Sayinalp N, Büyükaşik Y, Goker H and Ozcebe OI: Overexpression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leuk Lymphoma 47: 891-896, 2006. (Pubitemid 43840646)
30. Wulf GG, JahnsStreubel G, Strutz F, Basenau D, Hüfner M, Buske C, Wörmann B and Hiddemann W: Paraneoplastic hypokalemia in acute myeloid leukemia: A case of renin activity in AML blast cells. Ann Hematol 73: 139-141, 1996. (Pubitemid 26312964)
31. Wulf GG, Jahns-Streubel G, Nobiling R, Strutz F, Hemmerlein B, Hiddemann W and Wörmann B: Renin in acute myeloid leukaemia blasts. Br J Haematol 100: 335-337, 1998.
32. Lindberg H, Nielsen D, Jensen BV, Eriksen J and Skovsgaard T: Angiotensin-converting enzyme inhibitors for cancer treatment? Acta Oncol 43: 142-152, 2004. (Pubitemid 38478900)
33. Piskin O, Ozcan MA, Ozsan GH, Ates H, Demirkan F, Alacacioglu I and Undar B: Synergistic effect of imatinib mesylate and fludarabine combination on Philadelphia chromosome-positive chronic myeloid leukemia cell lines. Turk J Haematol 24: 23-27, 2007. (Pubitemid 47243933)
34. Haznedaroglu IC, Tuncer S and Gursoy M: A local renin-angiotensin system in the bone marrow. Med Hypotheses 46: 507-510, 1996. (Pubitemid 26184769)
35. Gomez RA, Norling LL, Wilfong N, Isakson P, Lynch KR, Hock R and Quesenberry P: Leukocytes synthesize angiotensinogen. Hypertension 21: 470-475, 1993. (Pubitemid 23095160)
36. Huckle WR and Earp HS: Regulation of cell proliferation and growth by angiotensin II. Prog Growth Factor Res 5: 177-194, 1994.
37. Okamura A, Raukugi H, Ohishi M, Yanagitani Y, Takiuchi S, Moriguchi K, Fennessy PA, Higaki J and Ogihara T: Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertension 17: 537-545, 1999. (Pubitemid 29308564)
38. Abali H, Haznedaroglu IC, Goker H, Celik I, Ozatli D, Koray Z and Caglar M: Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences. Hematology 7: 75-82, 2002. (Pubitemid 34700164)
39. Jokubaitis VJ, Sinka L, Driessen R, Whitty G, Haylock DN, Bertoncello I, Smith I, Péault B, Tavian M and Simmons PJ: Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 111: 4055-4063, 2008.
40. Zambidis ET, Soon Park T, Yu W, Tam A, Levine M, Yuan X, Pryzhkova M and Peault B: Expression of angiotensinconverting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112: 3601-3614, 2008.
41. Lever A, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL and Robertson JW: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352: 179-184, 1998. (Pubitemid 28327802)
42. Chisi JE, Wdzieczak-Bakala J, Thierry J, Briscoe CV and Riches AC: Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long term bone marrow cultures. Stem Cells 17: 339-344, 1999.
43. Chisi JE, Briscoe CV, Ezan E, Genet R, Riches AC and Wdzieczak-Bakala J: Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation. Br J Haematol 109: 563-570, 2000. (Pubitemid 30415183)
44. Comte L, Lorgeot V, Volkov L, Allegraud A, Aldigier JC and Praloran V: Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations. Eur J Clin Invest 27: 788-790, 1997. (Pubitemid 27414424)
45. Inigo SD, Lopez-Jorge CE, Gomez-Casares MT, Lemes Castellano A, Martin Cabrera P, Lopez Brito J, Suarez Cabrera A and Molero Labarta T: Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents. Leuk Res 33: 810-816, 2009.
46. Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184: 39-51, 1995.
47. Haznedaroglu IC, Arici M and Buyukasik Y: A unifying hypothesis for the renin-angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway. Med Hypotheses 54: 80-83, 2000. (Pubitemid 30156641)
48. van Eickels M, Grohe C, Lobbert K, Stimpel M and Vetter H: Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 359: 394-399, 1999. (Pubitemid 29252280)
49. Kim HW, Kim JL, Lee HK, Hur DY, Yun IH and Kim SD: Enalapril alters expression of key growth factors in experimental diabetic retinopathy. Curr Eye Res 34: 976-987, 2009.